NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Pharmacotherapy in Obesity: Not Just for Three Months
Overweight and obesity rates continue to climb worldwide, contributing to significant morbidity and mortality, despite several effective pharmacotherapy treatments that are grossly underutilized. Obesity is…
Cardiovascular Disease in the Rural American Population
Despite significant improvements in cardiovascular disease (CVD) outcomes and decline in overall CVD deaths, CVD continues to be the leading cause of death in the…
The Effects of Testosterone Therapy in Females on Lipid Parameters and Cardiovascular Disease Risk
In a systematic review and meta-analysis of 29 trials with moderate risk of bias, Maraka S. et al summarized the effect of sex hormone therapy…
Statin Use in Chronic Hepatitis C Infection, NAFLD/NASH, Cirrhosis and Hepatocellular Carcinoma
Case Presentation: G.S. is a 60-year-old male referred for cholesterol treatment complicated by background liver disease. He has a history of schizophrenia and chronic hepatitis C virus (HCV) diagnosed in 2016. He is asymptomatic and…